Simeprevir (TMC435) with Peginterferon/Ribavirin for chronic HCV genotype-1 infection in treatment-naïve patients: results from QUEST-1, a phase III trial

Authors
Category Primary study
ConferenceInternational Liver Congress: 48th Annual Meeting of the European Association for the Study of the Liver (EASL) April 24 - 28; Amsterdam, the Netherlands. Journal of Hepatology
Year 2013
This article has no abstract
Epistemonikos ID: 07b36fba8a51bf51f4269c3c070c9bc31e0dfd57
First added on: Feb 02, 2017